Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more

Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more
Centerspace jumps on report it's exploring a sale
Saint-Gobain to buy Australia's CSR in $3B deal
Optimism [OP] adds this CSR method on its mainnet – the result could…
1.11BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US15202L1070
CUSIP
15202L107
Sector
Real Estate
Industry
REIT - Residential
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
62.41
PEG Ratio
40.89
Book Value
42.91
Dividend Share
3.08
Dividend Yield
4.93%
Earnings Share
1.02
Wall Street Target Price
68.72
EPS Estimate Current Year
-1.12
EPS Estimate Next Year
-0.84
EPS Estimate Current Quarter
-0.2157
EPS Estimate Next Quarter
-0.2219
Most Recent Quarter
-
Revenue TTM
273,662,016
Gross Profit TTM
160,751,008
EBITDA
136,832,992
Profit Margin
6.43%
Return On Assets TTM
0.77%
Return On Equity TTM
2.63%
Revenue Per Share TTM
16.36
Qtly Revenue Growth YOY
0.30%
Diluted Eps TTM
1.02
Qtly Earnings Growth YOY
0.00%
Trailing PE
62.41
Forward PE
55
Price Sales TTM
4.1188
Price Book MRQ
1.4574
Enterprise Value Revenue
7
Enterprise Value EBITDA
11
34.25
0.29%26.29
0.02%64.27
0.02%29.96
0.00%122.30
-1.47%248.00
-1.45%60.49
-1.28%100.18
-1.13%169.63
-0.98%128.23
-0.40%